Ivimey
Ivimey is a patient who has benefited from comprehensive genomic profiling (CGP) and targeted therapy, having been diagnosed with cancer that harbored an EGFR gene mutation. After enrolling in a clinical trial for an EGFR inhibitor drug, she experienced a significant reduction in her tumor size, which allowed her to return to work and plan a family trip to Europe, showcasing the life-changing potential of personalized cancer treatments.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Ivimey became the first Australian to start treatment with another EGFR inhibitor via a compassionate access scheme.
9